Search Results - "Lin, Chuan‐Hao"

Network Change Detection Based on Random Walk in Latent Space by Lin, Chuan-Hao, Xu, Linchuan, Yamanishi, Kenji

“…The detection of network changes over time is based on identifying deviations of the network structure. The challenge mainly lies in designing a good summary…”
Get full text

The safety and effectiveness of ledipasvir−sofosbuvir in adolescents 12‐17 years old with hepatitis C virus genotype 1 infection by Balistreri, William F., Murray, Karen F., Rosenthal, Philip, Bansal, Sanjay, Lin, Chuan‐Hao, Kersey, Kathryn, Massetto, Benedetta, Zhu, Yanni, Kanwar, Bittoo, German, Polina, Svarovskaia, Evguenia, Brainard, Diana M., Wen, Jessica, Gonzalez‐Peralta, Regino P., Jonas, Maureen M., Schwarz, Kathleen

“…No all‐oral, direct‐acting antiviral regimens have been approved for children with chronic hepatitis C virus (HCV) infection. We conducted a phase 2,…”
Get full text

Sofosbuvir and ribavirin in adolescents 12‐17 years old with hepatitis C virus genotype 2 or 3 infection by Wirth, Stefan, Rosenthal, Philip, Gonzalez‐Peralta, Regino P., Jonas, Maureen M., Balistreri, William F., Lin, Chuan‐Hao, Hardikar, Winita, Kersey, Kathryn, Massetto, Benedetta, Kanwar, Bittoo, Brainard, Diana M., Shao, Jiang, Svarovskaia, Evguenia, Kirby, Brian, Arnon, Ronen, Murray, Karen F., Schwarz, Kathleen B.

“…Children with chronic hepatitis C virus infection have limited treatment options. We evaluated the all‐oral combination of sofosbuvir and ribavirin in…”
Get full text

Safety and Efficacy of Ledipasvir–Sofosbuvir With or Without Ribavirin for Chronic Hepatitis C in Children Ages 6‐11 by Murray, Karen F., Balistreri, William F., Bansal, Sanjay, Whitworth, Suzanne, Evans, Helen M., Gonzalez‐Peralta, Regino P., Wen, Jessica, Massetto, Benedetta, Kersey, Kathryn, Shao, Jiang, Garrison, Kimberly L., Parhy, Bandita, Brainard, Diana M., Arnon, Ronen, Gillis, Lynette A., Jonas, Maureen M., Lin, Chuan‐Hao, Narkewicz, Michael R., Schwarz, Kathleen, Rosenthal, Philip

“…Currently, there are no interferon‐free treatments available for hepatitis C virus (HCV)–infected patients younger than 12 years. We evaluated the safety and…”
Get full text

Sofosbuvir and Ribavirin Therapy for Children Aged 3 to <12 Years With Hepatitis C Virus Genotype 2 or 3 Infection by Rosenthal, Philip, Schwarz, Kathleen B., Gonzalez‐Peralta, Regino P., Lin, Chuan‐Hao, Kelly, Deidre A., Nightingale, Scott, Balistreri, William F., Bansal, Sanjay, Jonas, Maureen M., Massetto, Benedetta, Brainard, Diana M., Hsueh, Chia‐Hsiang, Shao, Jiang, Parhy, Bandita, Davison, Suzanne, Feiterna‐Sperling, Cornelia, Gillis, Lynette A., Indolfi, Giuseppe, Sokal, Etienne M., Murray, Karen F., Wirth, Stefan

“…Currently, the only approved hepatitis C virus (HCV) treatment for children aged <12 years is pegylated interferon plus ribavirin. In an open‐label study, we…”
Get full text

Change sign detection with differential MDL change statistics and its applications to COVID-19 pandemic analysis by Yamanishi, Kenji, Xu, Linchuan, Yuki, Ryo, Fukushima, Shintaro, Lin, Chuan-hao

“…We are concerned with the issue of detecting changes and their signs from a data stream. For example, when given time series of COVID-19 cases in a region, we…”
Get full text

Hepatitis C in 2020: A North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition Position Paper by Leung, Daniel H., Squires, James E., Jhaveri, Ravi, Kerkar, Nanda, Lin, Chuan-Hao, Mohan, Parvathi, Murray, Karen F., Gonzalez-Peralta, Regino P., Roberts, Eve A., Sundaram, Shikha S.

“…In 1989, a collaboration between the Centers for Disease Control (CDC) and a California biotechnology company identified the hepatitis C virus (HCV, formerly…”
Get full text

Sofosbuvir–velpatasvir in children 3–17 years old with hepatitis C virus infection by Jonas, Maureen M., Romero, Rene, Rosenthal, Philip, Lin, Chuan‐Hao, Verucchi, Gabriella, Wen, Jessica, Balistreri, William F., Whitworth, Suzanne, Bansal, Sanjay, Leung, Daniel H., Narkewicz, Michael R., Gonzalez‐Peralta, Regino P., Mangia, Alessandra, Karnsakul, Wikrom, Rao, Girish S., Shao, Jiang, Jong, Jan, Parhy, Bandita, Osinusi, Anu, Kersey, Kathryn, Murray, Karen F., Sokal, Etienne M., Schwarz, Kathleen B.

“…Background The safety and efficacy of sofosbuvir–velpatasvir in children aged 3–17 years with chronic hepatitis C virus (HCV) infection of any genotype were…”
Get full text

Transcriptional regulations of pollen tube reception are associated with the fertility of the ginger species Zingiber zerumbet and Zingiber corallinum by Liang, Shan, Hu, Ming-Li, Lin, Hao-Chuan, He, Han-Jun, Ning, Xi-Ping, Peng, Pei-Pei, Lu, Guo-Hui, Sun, Shu-Lan, Wang, Xiao-Jing, Wang, Ying-Qiang, Wu, Hong

“…and are economically valuable species in the genus . While is sexually active, adopts clonal propagation, although it has the potential for sexual…”
Get full text

A Prospective Trial of Withdrawal and Reinstitution of Ursodeoxycholic Acid in Pediatric Primary Sclerosing Cholangitis by Black, Dennis D., Mack, Cara, Kerkar, Nanda, Miloh, Tamir, Sundaram, Shikha S., Anand, Ravinder, Gupta, Ashutosh, Alonso, Estella, Arnon, Ronen, Bulut, Pinar, Karpen, Saul, Lin, Chuan‐Hao, Rosenthal, Philip, Ryan, Matthew, Squires, Robert H., Valentino, Pamela, Elsea, Sarah H., Shneider, Benjamin L.

“…Ursodeoxycholic acid (UDCA) is commonly used to treat several liver disorders in adults and children, including primary sclerosing cholangitis (PSC) for which…”
Get full text

Emerging New Diagnostic Modalities and Therapies of Nonalcoholic Fatty Liver Disease by Lin, Chuan-Hao, Kohli, Rohit

“…Purpose of Review Nonalcoholic fatty liver disease (NAFLD) has emerged as the leading cause of chronic liver disease in both adults and children. In this…”
Get full text

Bile acid metabolism and signaling: potential therapeutic target for nonalcoholic fatty liver disease by Lin, Chuan-Hao, Kohli, Rohit

“…Nonalcoholic fatty liver disease (NAFLD) has emerged as a leading cause of chronic liver disease. We now understand that NAFLD affects one out of every four…”
Get full text

A Prospective Study Comparing Oral Sodium Phosphate Solution to a Bowel Cleansing Preparation with Nutrition Food Package in Children by El‐Baba, Mohammad F, Padilla, Mary, Houston, Carmela, Madani, Shailender, Lin, Chuan‐Hao, Thomas, Ronald, Tolia, Vasundhara

“…ABSTRACT Objective: The inability of children to comply with bowel preparation regimens can result in inadequate visualization of the colon. This study…”
Get full text

Utility of hepatobiliary scintigraphy in diagnosing or excluding biliary atresia in premature neonates and full-term infants with conjugated hyperbilirubinemia who received parenteral nutrition by Barseghyan, Karine, Ramanathan, Rangasamy, Chavez, Thomas, Harlan, Susan, Lin, Chuan-Hao, Mitsinikos, Tania, McLean, Claire

“…Purpose: Hepatobiliary scintigraphy (HBS) is used to aid in the diagnosis of Biliary Atresia in full-term infants with conjugated hyperbilirubinemia. There is…”
Get full text

Severe Late-Onset Acute Cellular Rejection in a Pediatric Patient With Isolated Small Intestinal Transplant Rescued With Aggressive Immunosuppressive Approach: A Case Report by Narang, Amrita, Xi, Dong, Mitsinikos, Tania, Genyk, Yuri, Thomas, Dan, Kohli, Rohit, Lin, Chuan-Hao, Soufi, Nisreen, Warren, Mikako, Merritt, Russell, Yanni, George

“…Small intestinal transplantation is performed for patients with intestinal failure who failed other surgical and medical treatment. It carries notable risks,…”
Get full text

Hepatitis C in 2020 by Leung, Daniel H., Squires, James E., Jhaveri, Ravi, Kerkar, Nanda, Lin, Chuan‐Hao, Mohan, Parvathi, Murray, Karen F., Gonzalez‐Peralta, Regino P., Roberts, Eve A., Sundaram, Shikha S.

“…ABSTRACT In 1989, a collaboration between the Centers for Disease Control (CDC) and a California biotechnology company identified the hepatitis C virus (HCV,…”
Get full text

T lymphocyte abnormalities in juvenile systemic sclerosis patients by Reiff, Andreas, Weinberg, Kenneth I, Triche, Timothy, Masinsin, Bernadette, Mahadeo, Kris M, Lin, Chuan-Hao, Brown, Diane, Parkman, Robertson

“…Abstract Multi-center evaluations of pediatric patients with juvenile systemic sclerosis (jSSc) have suggested that the pathogenesis of jSSc may differ from…”
Get full text

Maralixibat in progressive familial intrahepatic cholestasis (MARCH-PFIC): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial by Miethke, Alexander G, Moukarzel, Adib, Porta, Gilda, Covarrubias Esquer, Joshue, Czubkowski, Piotr, Ordonez, Felipe, Mosca, Antonella, Aqul, Amal A, Squires, Robert H, Sokal, Etienne, D'Agostino, Daniel, Baumann, Ulrich, D'Antiga, Lorenzo, Kasi, Nagraj, Laborde, Nolwenn, Arikan, Cigdem, Lin, Chuan-Hao, Gilmour, Susan, Mittal, Naveen, Chiou, Fang Kuan, Horslen, Simon P, Huber, Wolf-Dietrich, Jaecklin, Thomas, Nunes, Tiago, Lascau, Anamaria, Longpre, Lara, Mogul, Douglas B, Garner, Will, Vig, Pamela, Hupertz, Vera F, Gonzalez-Peralta, Regino P, Ekong, Udeme, Hartley, Jane, Laverdure, Noemie, Ovchinsky, Nadia, Thompson, Richard J

“…Progressive familial intrahepatic cholestasis (PFIC) is a group of autosomal recessive disorders, the most prevalent being BSEP deficiency, resulting in…”
Get more information

P-6 SOFOSBUVIR CONTAINING REGIMENS ARE SAFE AND EFFECTIVE IN ADOLESCENTS WITH CHRONIC HEPATITIS C INFECTION by Wirth, Stefan, Gonzalez-Peralta, Regino, Rosenthal, Philip, Hardikar, Winita, Wen, Jessica, Jonas, Maureen M., Mittal, Naveen, Whitworth, Mary, Arnon, Ronen, Lin, Chuan-Hao, Lobzin, Yury, Romero, Rene, Chulanov, Vladimir, Subbarao, Girish, Teckman, Jeffrey, Morozov, Vyacheslav, Bassetti, Eric, Kersey, Kathryn, Massetto, Benedetta, Zhu, Yanni, German, Polina, Brainard, Diana M., Bansal, Sanjay, Murray, Karen F., Schwarz, Kathleen, Balistreri, William

“…HCV-specific DAAs have transformed treatment of chronic HCV, but few studies have evaluated these therapies in children. Patients aged 12–17 years old with…”
Get full text

A Prospective Trial of Lansoprazole Triple Therapy for Pediatric Helicobacter pylori Infection by Shashidhar, Harohalli, Peters, John, Lin, Chuan-Hao, Rabah, Rajah, Thomas, Ronald, Tolia, Vasundhara

“…BACKGROUND:Triple therapy with a proton-pump inhibitor and two antibiotics is widely used in the treatment of Helicobacter pylori infection in adults…”
Get full text